Published in Int J Epidemiol on December 01, 2015
The dog aging project: translational geroscience in companion animals. Mamm Genome (2016) 0.79
Biomarker signatures of aging. Aging Cell (2017) 0.78
Oxidative Stress and Salvia miltiorrhiza in Aging-Associated Cardiovascular Diseases. Oxid Med Cell Longev (2016) 0.76
Reducing exposure to cardiovascular risk factors: the legacy of prevention. J Thorac Dis (2016) 0.75
Understanding the Causes and Implications of Endothelial Metabolic Variation in Cardiovascular Disease through Genome-Scale Metabolic Modeling. Front Cardiovasc Med (2016) 0.75
Northern Shanghai Study: cardiovascular risk and its associated factors in the Chinese elderly-a study protocol of a prospective study design. BMJ Open (2017) 0.75
The spread of obesity in a large social network over 32 years. N Engl J Med (2007) 34.75
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet (2008) 20.66
Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health (1951) 20.27
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med (1990) 17.52
The collective dynamics of smoking in a large social network. N Engl J Med (2008) 15.96
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation (1983) 12.63
Metabolite profiles and the risk of developing diabetes. Nat Med (2011) 12.22
Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. Ann Intern Med (1961) 12.08
Diabetes and cardiovascular disease. The Framingham study. JAMA (1979) 11.95
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol (2007) 9.90
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation (2010) 9.09
Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med (1982) 8.62
Genetic studies of body mass index yield new insights for obesity biology. Nature (2015) 8.27
Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension (2004) 8.27
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med (1971) 7.46
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation (1996) 6.20
Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med (2011) 5.94
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol (1999) 5.43
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37
Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol (1971) 4.90
Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation (2004) 4.73
Some health benefits of physical activity. The Framingham Study. Arch Intern Med (1979) 4.63
Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation (2009) 4.62
Coronary heart disease in the Framingham study. Am J Public Health Nations Health (1957) 4.13
Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA (1987) 4.05
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA (1996) 3.68
Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes (2000) 3.60
Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation (2003) 3.46
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. Nature (2014) 3.29
Premature mortality from coronary heart disease. The Framingham study. JAMA (1971) 3.15
Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol (1995) 3.08
Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness. BMC Med Genet (2007) 3.04
Genetic associations with valvular calcification and aortic stenosis. N Engl J Med (2013) 3.02
50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet (2015) 3.02
Candidate gene association resource (CARe): design, methods, and proof of concept. Circ Cardiovasc Genet (2010) 2.91
Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med (1972) 2.91
Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke (2008) 2.84
Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med (1997) 2.81
Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA (1988) 2.68
Whole-genome sequence-based analysis of high-density lipoprotein cholesterol. Nat Genet (2013) 2.62
Cigarette smoking and coronary heart disease. Combined experience of the Albany and Framingham studies. N Engl J Med (1962) 2.62
The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. JAMA (1988) 2.59
Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation (2012) 2.51
Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol (2012) 2.47
Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. Am J Hum Genet (2014) 2.33
Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort. J Am Coll Cardiol (2002) 2.33
Prognosis after initial myocardial infarction: the Framingham study. Am J Cardiol (1979) 2.30
Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med (1988) 2.30
Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation (1997) 2.29
Visceral and subcutaneous fat quality and cardiometabolic risk. JACC Cardiovasc Imaging (2013) 2.19
Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data. JAMA (2009) 2.10
Prognostic implications of asymptomatic ventricular arrhythmias: the Framingham Heart Study. Ann Intern Med (1992) 2.08
Cigarette smoking as a confounder of the relationship between relative weight and long-term mortality. The Framingham Heart Study. JAMA (1983) 2.00
Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med (1989) 1.95
Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. Nat Genet (2011) 1.92
Evaluation of cardiovascular risk in the elderly: the Framingham study. Bull N Y Acad Med (1978) 1.92
Parental history is an independent risk factor for coronary artery disease: the Framingham Study. Am Heart J (1990) 1.87
Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. Am J Hum Genet (2014) 1.86
The natural history of borderline isolated systolic hypertension. N Engl J Med (1993) 1.82
The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. Arch Intern Med (2003) 1.81
Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study. Circulation (2009) 1.75
Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study. BMC Med Genet (2007) 1.65
Lifetime risk of coronary heart disease by cholesterol levels at selected ages. Arch Intern Med (2003) 1.64
Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study. Circulation (2010) 1.62
Integromic analysis of genetic variation and gene expression identifies networks for cardiovascular disease phenotypes. Circulation (2014) 1.55
Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. Circulation (1996) 1.47
Blood pressure aggregation in families. Am J Epidemiol (1979) 1.45
Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes (1992) 1.36
Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. Nat Commun (2015) 1.27
Summary estimates of cholesterol used to predict coronary heart disease. Circulation (1983) 1.26
Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation (2015) 1.25
A systems biology framework identifies molecular underpinnings of coronary heart disease. Arterioscler Thromb Vasc Biol (2013) 1.18
The silent coronary: the frequency and clinical characteristics of unrecognized myocardial infarction in the Framingham study. Ann Intern Med (1959) 1.12
Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium. Circ Cardiovasc Genet (2011) 1.11
Fat quality and incident cardiovascular disease, all-cause mortality, and cancer mortality. J Clin Endocrinol Metab (2015) 1.10
Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study. Diabetes (1989) 1.09
Gene expression signatures of coronary heart disease. Arterioscler Thromb Vasc Biol (2013) 1.08
Is hyperglycemia associated with cardiovascular disease? The Framingham Study. Am Heart J (1991) 1.07
The Framingham Study. Cigarettes and the development of intermittent claudication. Geriatrics (1973) 1.06
Relations of circulating resistin and adiponectin and cardiac structure and function: the Framingham Offspring Study. Obesity (Silver Spring) (2011) 1.05
Becoming the Framingham Study 1947-1950. Am J Public Health (2005) 1.05
Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community. Arterioscler Thromb Vasc Biol (2013) 1.05
The association of total cholesterol, triglycerides and plasma lipoprotein cholesterol levels in first degree relatives and spouse pairs. Am J Epidemiol (1979) 1.05
Hypertension. Relationship with other risk factors. Drugs (1986) 1.02